In each of these studies, the miRNA was able to reduce breast cancer stemness markers [76,91] or sensitize breast cancer cells to chemotherapy [91,109], and this was accomplished in part due to the direct targeting of Notch1. This evidence concerns the gene NOTCH1 and breast carcinoma.